APG Asset Management US Inc. lessened its holdings in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC – Free Report) by 6.1% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 9,437 shares of the company’s stock after selling 611 shares during the period. APG Asset Management US Inc.’s holdings in GE HealthCare Technologies were worth $738,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other hedge funds also recently made changes to their positions in GEHC. CoreFirst Bank & Trust bought a new stake in GE HealthCare Technologies during the fourth quarter worth approximately $25,000. Runnymede Capital Advisors Inc. bought a new stake in GE HealthCare Technologies during the fourth quarter worth approximately $28,000. Continuum Advisory LLC raised its holdings in GE HealthCare Technologies by 101.8% during the third quarter. Continuum Advisory LLC now owns 333 shares of the company’s stock worth $31,000 after purchasing an additional 168 shares in the last quarter. Bank of Jackson Hole Trust bought a new stake in GE HealthCare Technologies during the fourth quarter worth approximately $32,000. Finally, OFI Invest Asset Management bought a new stake in GE HealthCare Technologies during the fourth quarter worth approximately $34,000. Institutional investors own 82.06% of the company’s stock.
Analyst Upgrades and Downgrades
GEHC has been the topic of several recent analyst reports. Jefferies Financial Group raised GE HealthCare Technologies from a “hold” rating to a “buy” rating and boosted their target price for the stock from $95.00 to $103.00 in a report on Wednesday, January 8th. Wells Fargo & Company lifted their price target on shares of GE HealthCare Technologies from $96.00 to $103.00 and gave the stock an “overweight” rating in a research report on Friday, February 14th. Citigroup lifted their price target on shares of GE HealthCare Technologies from $103.00 to $110.00 and gave the stock a “buy” rating in a research report on Thursday, February 13th. Finally, The Goldman Sachs Group upgraded shares of GE HealthCare Technologies from a “neutral” rating to a “buy” rating and lifted their price target for the stock from $85.00 to $100.00 in a research report on Tuesday, March 11th. One investment analyst has rated the stock with a sell rating, two have issued a hold rating, eight have given a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $97.73.
GE HealthCare Technologies Trading Up 10.6 %
GE HealthCare Technologies stock opened at $64.98 on Thursday. The company’s fifty day simple moving average is $82.73 and its 200-day simple moving average is $84.47. The company has a quick ratio of 0.83, a current ratio of 1.04 and a debt-to-equity ratio of 0.88. GE HealthCare Technologies Inc. has a 12 month low of $57.65 and a 12 month high of $94.80. The stock has a market cap of $29.72 billion, a P/E ratio of 15.01, a P/E/G ratio of 3.19 and a beta of 1.14.
GE HealthCare Technologies (NASDAQ:GEHC – Get Free Report) last posted its quarterly earnings results on Thursday, February 13th. The company reported $1.45 EPS for the quarter, beating the consensus estimate of $1.26 by $0.19. GE HealthCare Technologies had a net margin of 10.13% and a return on equity of 25.74%. The business had revenue of $5.32 billion for the quarter, compared to analysts’ expectations of $5.33 billion. As a group, sell-side analysts forecast that GE HealthCare Technologies Inc. will post 4.68 EPS for the current fiscal year.
GE HealthCare Technologies Dividend Announcement
The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, May 15th. Investors of record on Friday, April 25th will be paid a $0.035 dividend. This represents a $0.14 annualized dividend and a dividend yield of 0.22%. The ex-dividend date is Friday, April 25th. GE HealthCare Technologies’s payout ratio is presently 3.23%.
About GE HealthCare Technologies
GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.
See Also
- Five stocks we like better than GE HealthCare Technologies
- What is the S&P 500 and How It is Distinct from Other Indexes
- Quantum Computing: The $6.5 Billion Opportunity You Can’t Ignore
- 3 Home Improvement Stocks that Can Upgrade Your Portfolio
- Are Tariffs Threatening Disney’s Comeback Story?
- What is a support level?
- Is Alphabet a Generational Buying Opportunity at These Levels?
Want to see what other hedge funds are holding GEHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for GE HealthCare Technologies Inc. (NASDAQ:GEHC – Free Report).
Receive News & Ratings for GE HealthCare Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GE HealthCare Technologies and related companies with MarketBeat.com's FREE daily email newsletter.